Search PubMed⌕ Search

Biomedical subjects

D Kaiser

Publications and source records attributed to D Kaiser.

248 records · Page 14Linked to original sources

In vitro assembly of bacteriophage Lambda heads.

The assembly of plaque-forming particles in cell-free extracts of induced lambda lysogens was observed two ways. (i) DNA isolated from a lambda-related phage, 434 for example, is added to an extract of an induced lambda lysogen, and plaque-formers with the genotype of the added DNA are detected. (ii) One extract from an induced lambda lysogen that carries an amber mutation in one of the head genes (A, B, C, D, or E) is mixed with one carrying an amber mutation in a different head gene; an increase in the number of lambda plaque-formers is found over that in either extract alone. These plaque-forming particles have the properties of normal phage particles. They are resistant to DNase, although DNase added to an extract before addition of DNA prevents their appearance; they have a sensitivity to neutralizing antibody and a specificity of adsorption to bacteria characteristic of the source of the extract, but they have the genotype of the added DNA; and they have about the same bouyant density as phage particles. Mutants in genes B, C, or D can donate DNA to the phage formed by complementation between extracts of different mutants, but mutants in genes A or E cannot. Complementation occurs between a pair of extracts only if one (or both) is a DNA donor. This observation suggests a tentative pathway for head assembly: that the products of genes A and E act before those of B, C, and D.

Centrifugation, Density Gradient↗

CA 19-9, CA 50 and elastase 1 as additional markers of cystic fibrosis.

Since reliable diagnosis of cystic fibrosis (CF) is still difficult, the occurrence of serum markers CA 19-9, CA 50 and elastase 1 was analysed. Serum levels of CA 19-9, CA 50, CA 125 and elastase 1 were estimated in 54 CF patients as well as in a control group of 66 children of similar age suffering from various other diseases and in 57 parents of CF patients. In 67% of CF patients CA 19-9 was higher than 37 U/ml, whereas 8% of the control group and only 2% of the parents showed an increased concentration. In the case of CA 50, 65% of the CF group, 21% of the control and none of the parents exhibited concentrations higher than 17 U/ml. In CF 22% showed decreased, 8% increased elastase 1 values. In the control group 2% had less than 80 ng/dl and 3% had higher elastase 1 levels than 400 ng/dl. In parents there were only increased levels in 4%. Accordingly CA 19-9 has been proven as a suitable marker and its sensitivity can be improved from 67% to 86% by additional testing of CA 50 and elastase 1. With regard to CA 125 in 11% of CF patients, 5% of control persons and 5% of parents CA 125 levels ranged above 35 U/ml. The determination of saliva CA 19-9 and CA 125 does not yield further information. Taking all previous findings into account elastase 1 is a better marker for acute pancreatitis than for pancreatic cancer and CF.(ABSTRACT TRUNCATED AT 250 WORDS)

Adolescent↗